Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Khadija Khan, Farina Karim, Yashica Ganga, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 550
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 273
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 239
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 212
A multinational Delphi consensus to end the COVID-19 public health threat
Jeffrey V. Lazarus, Diana Romero, Christopher J. Kopka, et al.
Nature (2022) Vol. 611, Iss. 7935, pp. 332-345
Open Access | Times Cited: 172
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Hung Fu Tseng, Bradley K. Ackerson, Katia Bruxvoort, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 90
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 80
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khadija Khan, Gila Lustig, Cornelius Römer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 70
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Population immunity predicts evolutionary trajectories of SARS-CoV-2
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5151-5164.e13
Open Access | Times Cited: 43
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 41
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Julia M. Adler, Ricardo Martin Vidal, Christine Langner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Mary‐Ann Davies, Erna Morden, Petro Rousseau, et al.
International Journal of Infectious Diseases (2022) Vol. 127, pp. 63-68
Open Access | Times Cited: 57
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
Nicole P. Hachmann, Jessica Miller, Ai‐ris Y. Collier, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 20, pp. 1904-1906
Open Access | Times Cited: 54
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 47, pp. E1599-E1609
Open Access | Times Cited: 45
Next-generation nanophotonic-enabled biosensors for intelligent diagnosis of SARS-CoV-2 variants
Bakr Ahmed Taha, Yousif Al Mashhadany, Qussay Al-Jubouri, et al.
The Science of The Total Environment (2023) Vol. 880, pp. 163333-163333
Open Access | Times Cited: 38
When to update COVID-19 vaccine composition
Rebecca Grant, Jilian A. Sacks, Priya Abraham, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 776-780
Open Access | Times Cited: 37
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
Lidong Wang, Michelle Møhlenberg, Pengfei Wang, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 13-25
Open Access | Times Cited: 32
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1010870-e1010870
Open Access | Times Cited: 24
What makes SARS‐CoV‐2 unique? Focusing on the spike protein
Jingbo Qian, Shi-Chang Zhang, Fang Wang, et al.
Cell Biology International (2024) Vol. 48, Iss. 4, pp. 404-430
Open Access | Times Cited: 12
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 537-551
Open Access | Times Cited: 12
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top